Development of the allergy outcome survey for allergic rhinitis.
The Allergy Outcome Survey (AOS) is a reliable measure used to monitor patients with allergic rhinitis. It was developed for and included in the Outcomes Measures of Immunotherapy in Allergic Rhinitis (OMIAR-1) project, designed to study the benefits of immunotherapy in the treatment of allergic rhinitis. Preliminary results indicate that AOS is specific, brief, reliable, and easy to use. Also, it is useful for evaluating change with therapy and can be used alone as a performance metric or in combination with other measures as part of a more complete outcomes monitoring system. As the OMIAR-1 study progresses, more information will be available on the advantages and limitations of the AOS.
Kemker
B J
BJ
Department of Otolaryngology-Head and Neck Surgery, University of Chicago, IL 60637, USA.
Corey
J P
JP
Branca
J
J
Gliklich
R E
RE
D015331:Cohort Studies; D003627:Data Interpretation, Statistical; D003888:Desensitization, Immunologic; D005500:Follow-Up Studies; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data; D015203:Reproducibility of Results; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000628:therapy*